DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,746,428 | +5.7% | 7,039 | +2.3% | 0.02% | +4.2% |
| Q2 2023 | $1,651,730 | +2.3% | 6,882 | +13.1% | 0.02% | -17.2% |
| Q1 2023 | $1,614,871 | 0.0% | 6,084 | 0.0% | 0.03% | 0.0% |
| Q4 2022 | $1,614,871 | +2.9% | 6,084 | +0.1% | 0.03% | -9.4% |
| Q3 2022 | $1,569,000 | +16.1% | 6,075 | +14.0% | 0.03% | +18.5% |
| Q2 2022 | $1,352,000 | -14.2% | 5,331 | -0.7% | 0.03% | -12.9% |
| Q1 2022 | $1,575,000 | -13.9% | 5,369 | -3.4% | 0.03% | -11.4% |
| Q4 2021 | $1,829,000 | +5.6% | 5,560 | -2.3% | 0.04% | 0.0% |
| Q3 2021 | $1,732,000 | +23.6% | 5,689 | +9.0% | 0.04% | +2.9% |
| Q2 2021 | $1,401,000 | +79.4% | 5,219 | +50.4% | 0.03% | -12.8% |
| Q1 2021 | $781,000 | -12.0% | 3,469 | -13.2% | 0.04% | -17.0% |
| Q4 2020 | $887,000 | +4.6% | 3,995 | +1.5% | 0.05% | -27.7% |
| Q3 2020 | $848,000 | +6.9% | 3,937 | -12.2% | 0.06% | -13.3% |
| Q2 2020 | $793,000 | -12.3% | 4,483 | -31.4% | 0.08% | -13.8% |
| Q1 2020 | $904,000 | -10.0% | 6,535 | -0.1% | 0.09% | -9.4% |
| Q4 2019 | $1,004,000 | +7.7% | 6,541 | +1.4% | 0.10% | -5.0% |
| Q3 2019 | $932,000 | +2.2% | 6,450 | +1.1% | 0.10% | +2.0% |
| Q2 2019 | $912,000 | +8.1% | 6,381 | -0.2% | 0.10% | -6.6% |
| Q1 2019 | $844,000 | +28.7% | 6,394 | +0.6% | 0.11% | +6.0% |
| Q4 2018 | $656,000 | -13.6% | 6,359 | -8.9% | 0.10% | -13.8% |
| Q3 2018 | $759,000 | +12.4% | 6,981 | +2.1% | 0.12% | +6.4% |
| Q2 2018 | $675,000 | -24.7% | 6,838 | -25.3% | 0.11% | -37.7% |
| Q1 2018 | $897,000 | +6.5% | 9,157 | +1.0% | 0.18% | -0.6% |
| Q4 2017 | $842,000 | +70.4% | 9,070 | +57.6% | 0.18% | +50.4% |
| Q3 2017 | $494,000 | +1.2% | 5,755 | -0.4% | 0.12% | +1.7% |
| Q2 2017 | $488,000 | -0.8% | 5,778 | +0.4% | 0.12% | -19.6% |
| Q1 2017 | $492,000 | +19.4% | 5,754 | +8.7% | 0.14% | +7.5% |
| Q4 2016 | $412,000 | -6.2% | 5,293 | -5.5% | 0.13% | -10.7% |
| Q3 2016 | $439,000 | -21.7% | 5,600 | +0.7% | 0.15% | -22.0% |
| Q2 2016 | $561,000 | +7.5% | 5,559 | +1.0% | 0.19% | +10.4% |
| Q1 2016 | $522,000 | +45.4% | 5,505 | +42.5% | 0.17% | +44.2% |
| Q4 2015 | $359,000 | +13.6% | 3,864 | +4.2% | 0.12% | +8.1% |
| Q3 2015 | $316,000 | +5.3% | 3,709 | +5.9% | 0.11% | +13.3% |
| Q2 2015 | $300,000 | -0.3% | 3,504 | -1.1% | 0.10% | -13.3% |
| Q1 2015 | $301,000 | -1.0% | 3,544 | 0.0% | 0.11% | -4.2% |
| Q4 2014 | $304,000 | +10.1% | 3,544 | -2.4% | 0.12% | +3.5% |
| Q3 2014 | $276,000 | -4.8% | 3,630 | -1.3% | 0.11% | -10.2% |
| Q2 2014 | $290,000 | +3.2% | 3,679 | -1.6% | 0.13% | -2.3% |
| Q1 2014 | $281,000 | -1.7% | 3,740 | +0.9% | 0.13% | -3.7% |
| Q4 2013 | $286,000 | -1.0% | 3,705 | -11.0% | 0.14% | -11.8% |
| Q3 2013 | $289,000 | +9.5% | 4,163 | 0.0% | 0.15% | +2.7% |
| Q2 2013 | $264,000 | – | 4,163 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |